Cystic Fibrosis: Clinical Trials

1,583 trials for Cystic Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1042 completed, 161 unknown, 122 recruiting, 119 terminated. 431 Not applicable, 252 Phase 2, 187 Phase 1, 169 Phase 3, 88 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable431Completed 269, Unknown 52, Terminated 34, Recruiting 27, Withdrawn 22, Not yet recruiting 15, Active not recruiting 8, Enrolling by invitation 2, Suspended 2
Phase 2252Completed 179, Terminated 36, Recruiting 12, Unknown 12, Withdrawn 7, Active not recruiting 3, Not yet recruiting 2, Suspended 1
Phase 1187Completed 153, Terminated 12, Recruiting 8, Withdrawn 6, Unknown 4, Active not recruiting 2, Not yet recruiting 1, Suspended 1
Phase 3169Completed 135, Terminated 13, Active not recruiting 6, Unknown 6, Withdrawn 6, Recruiting 2, Enrolling by invitation 1
Phase 488Completed 55, Terminated 15, Unknown 7, Recruiting 5, Active not recruiting 3, Withdrawn 2, Not yet recruiting 1
Early Phase 114Completed 7, Recruiting 4, Terminated 2, Active not recruiting 1

Follow Cystic Fibrosis: new trials by email Literature Review of Cystic Fibrosis trials Research Report on Cystic Fibrosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers
Cystic Fibrosis, Pregnancy
Not yet recruitingUniversity of Minnesota302027-01-012026-01-20
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes
RecruitingBettina Mittendorfer1002027-01-012026-05-07
Type 2 Inflammation in Adults With Cystic Fibrosis
Cystic Fibrosis (CF), Type 2 Inflammatory Disorders
Not yet recruitingUniversity of Virginia1002026-11-012026-10-23
Reproducibility of Continuous Glucose Monitoring (CGM) in the Assessment of Glucose Metabolism Disorders in Children With Cystic Fibrosis
Continuous Glucose Monitoring, Eating Habits Questionnaire, Use of an actigraphy watch - Glucose Metabolism Disorders in Cystic Fibrosis
Not applicableNot yet recruitingHospices Civils de Lyon302026-11-012026-10-01
Management of Breast Fibroadenoma: Comparing Observation, Microwave Ablation, and Surgical Excision
Ultrasound-guided percutaneous microwave ablation, Conventional open surgical excision - Fibroadenoma, Breast Fibroadenoma
Not applicableNot yet recruitingSohag University602026-11-012026-10-22
Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function
micro Sweat Test Patch (mSTP), Sweat Testing using SOC - Cystic Fibrosis
Not applicableNot yet recruitingEmory University3002026-11-012026-10-27
Iron Repletion in Cystic Fibrosis
IV Repletion, PO Repletion - Cystic Fibrosis, Iron Deficiencies
Phase 4Not yet recruitingUniversity of Michigan1002026-11-012026-10-29
Nutrition Supplement for Cystic Fibrosis
Common form supplementation, Uncommon nutrient supplementation - Cystic Fibrosis (CF)
Not applicableNot yet recruitingOhio State University602026-10-152026-09-21
Vascular Health and Function in Cystic Fibrosis
Non-invasive vascular, cerebrovascular and autonomic assessment - Cystic Fibrosis, Endothelial Dysfunction
Not yet recruitingLiverpool Heart and Chest Hospital NHS Foundation Trust1002026-10-102026-10-29
SPutum Induction and Nebuliser deviCEs for Patients With CF
Sputum induction - Cystic Fibrosis (CF), Cystic Fibrosis Lung Disease
Not applicableNot yet recruitingRoyal Brompton & Harefield NHS Foundation Trust302026-10-012026-10-19
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
NHS7108, Zenpep® - Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2RecruitingAimmune Nestlé Health Science US R&D, LLC662026-10-012026-10-01
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
VX-581 - Cystic Fibrosis
Phase 1Active not recruitingVertex Pharmaceuticals Incorporated162026-09-232026-10-27
Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis
Elexacaftor, Tezacaftor, Ivacaftor, Ivacaftor (VX-770) - Cystic Fibrosis (CF)
Phase 4RecruitingIstituto Giannina Gaslini502026-09-182026-10-14
Rethinking Early Airway Clearence Therapies
As-needed hypertonic saline (HS), Twice daily hypertonic saline (HS), As-needed dornase alfa (DA) - Cystic Fibrosis (CF)
Not applicableNot yet recruitingNicole Hamblett4052026-09-152026-07-10
Heart and Blood Vessels Health in People With Cystic Fibrosis
Cystic Fibrosis (CF), Cardiovascular (CV) Risk
Not yet recruitingLiverpool Heart and Chest Hospital NHS Foundation Trust322026-09-012026-08-14
Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
Mediterranean diet - Cystic Fibrosis (CF), Cystic Fibrosis Gastrointestinal Disease
Not applicableRecruitingDartmouth-Hitchcock Medical Center202026-09-012026-07-02
MRI Parameters as Biomarkers in Cystic Fibrosis (FEMPTO)
Linaclotide 290 micrograms, Placebo - Cystic Fibrosis (CF)
Not applicableNot yet recruitingUniversity of Nottingham122026-09-012026-08-21
Home Air Pollution in Children With Cystic Fibrosis Study
Cystic Fibrosis (CF)
Not yet recruitingSeattle Children's Hospital2002026-09-012026-06-24
Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection
AchromoPhage - Cystic Fibrosis (CF), Achromobacter Infection
Phase 1RecruitingGhady Haidar122026-08-202026-10-08
Verapamil Effect in Cystic Fibrosis-related Dysglycemia
Verapamil Hydrochloride - Cystic Fibrosis Related Diabetes, Cystic Fibrosis (CF)
Phase 2Not yet recruitingRhode Island Hospital302026-08-012026-07-09

Showing 20 of 1583. Sign in to see all of them.

Narrower conditions

Lung Diseases (57)  ·  Pseudomonas Infections (56)  ·  Exocrine Pancreatic Insufficiency (54)  ·  Pulmonary Disease, Chronic Obstructive (49)  ·  Asthma (47)  ·  Motor Activity (41)  ·  Respiratory Tract Diseases (39)  ·  Diabetes Mellitus (38)  ·  Bronchiectasis (36)  ·  Genetic Diseases, Inborn (33)  ·  Inflammation (24)  ·  Rare Diseases (21)  ·  Ciliary Motility Disorders (18)  ·  Pancreatic Diseases (18)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1582)  ·  Infant, Newborn, Diseases (1577)  ·  Digestive System Diseases (1569)  ·  Pancreatic Diseases (1565)  ·  Genetic Diseases, Inborn (1550)  ·  Respiratory Tract Diseases (1544)  ·  Lung Diseases (1526)  ·  Pathological Conditions, Signs and Symptoms (215)  ·  Pathologic Processes (154)  ·  Infections (141)  ·  Bacterial Infections and Mycoses (98)  ·  Disease Attributes (97)  ·  Nutritional and Metabolic Diseases (90)  ·  Bacterial Infections (83)  ·  Metabolic Diseases (83)

Interventions

ivacaftor (108)  ·  elexacaftor, ivacaftor, tezacaftor drug combination (36)  ·  Inhalation (25)  ·  Exercise (24)  ·  Sodium Chloride (23)  ·  tezacaftor, ivacaftor drug combination (22)  ·  Tobramycin (21)  ·  Saline Solution, Hypertonic (20)  ·  tezacaftor (20)  ·  Blood Specimen Collection (19)  ·  lumacaftor, ivacaftor drug combination (19)  ·  Surveys and Questionnaires (15)  ·  lumacaftor (15)  ·  Cholecalciferol (13)  ·  Pancrelipase (13)

Sponsors

Vertex Pharmaceuticals Incorporated (117)  ·  Hospices Civils de Lyon (33)  ·  Assistance Publique - Hôpitaux de Paris (31)  ·  Gilead Sciences (22)  ·  National Jewish Health (21)  ·  University of North Carolina, Chapel Hill (20)  ·  Children's Hospital Medical Center, Cincinnati (17)  ·  The Hospital for Sick Children (17)  ·  University of Alabama at Birmingham (17)  ·  Novartis Pharmaceuticals (16)  ·  Royal Brompton & Harefield NHS Foundation Trust (16)  ·  University Hospital, Montpellier (16)  ·  University of British Columbia (16)  ·  Boston Children's Hospital (15)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (15)

Countries

United States (699)  ·  France (245)  ·  United Kingdom (231)  ·  Canada (177)  ·  Germany (144)  ·  Belgium (117)  ·  Australia (105)  ·  Italy (85)  ·  Spain (85)  ·  Netherlands (76)  ·  Israel (61)  ·  Turkey (Türkiye) (47)  ·  Ireland (43)  ·  Poland (43)  ·  Sweden (40)

Top investigators

Felix Ratjen, MD (9)  ·  Margaret Rosenfeld, MD, MPH (8)  ·  Eitan Kerem, MD (6)  ·  Gina Eagle, MD (6)  ·  Scott Donaldson, MD (6)  ·  Alan Smyth (5)  ·  Jason Woods, PhD (5)  ·  Nicole Mayer-Hamblett, PhD (5)  ·  Amy Schaberg, BSN (4)  ·  Antoinette Moran, MD (4)

Results publications

PMID 37983082, PMID 33331662, PMID 33735508, PMID 37319354, PMID 32671834, PMID 27009167, PMID 31215818, PMID 32761612, PMID 36509366, PMID 36511181, PMID 25981758, PMID 33331663, PMID 36866921, PMID 15065835, PMID 19717485, PMID 22805498, PMID 24464974, PMID 24743971, PMID 25819269, PMID 26070913, PMID 26709158, PMID 27298017, PMID 30146268, PMID 30334693, PMID 30587335, PMID 31056441, PMID 32358807, PMID 33105385, PMID 33303537, PMID 34929010, PMID 35227647, PMID 36625789, PMID 36842446, PMID 37683122, PMID 38145393, PMID 39255452, PMID 39756424, PMID 10459902, PMID 11013547, PMID 11179102, PMID 11344348, PMID 11451820, PMID 11562511, PMID 11742607, PMID 11809990, PMID 11834520, PMID 11866011, PMID 11921459, PMID 12004158, PMID 12052307

NIH funding

2017 (16), 2018 (15), 2019 (11), 2015 (10), 2016 (10), 2014 (8), 2008 (7), 2009 (7), 2023 (5), UL1TR001082 (3), P50HL084932 (2), R01HL108929 (2), R01HL116226 (2), R01HL131012 (2), R01HL161164 (2)